Bevacizumab vs ranibizumab for neovascular age-related macular degeneration in Chinese patients

Bevacizumab vs ranibizumab for neovascular age-related macular degeneration in Chinese patients

AIM:To compare the clinical efficacy of intravitreal injections of bevacizumab and ranibizumab for treating Chinese patients with neovascular age-related macular degeneration (AMD). METHODS: Among 60 Chinese patients with exudative AMD (60 eyes), 28 received intravitreal bevacizumab injections (1...

Full description

Bibliographic Details
Main Authors: Zhe-Li Liu, Feng Gu, Peng Sun, Han Zhang, Jun Li
Format: Article
Language:English
Published: Press of International Journal of Ophthalmology (IJO PRESS) 2013-04-01
Series:International Journal of Ophthalmology
Subjects:
age-related macular degeneration
choroidal neovascularization
bevacizumab (avastin)
ranibizumab (lucentis)
Online Access:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3633755/

Similar Items

Similar Items